nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—GSTM1—Carboplatin—ovarian cancer	0.395	0.605	CbGbCtD
Azathioprine—XDH—Carboplatin—ovarian cancer	0.164	0.251	CbGbCtD
Azathioprine—XDH—Doxorubicin—ovarian cancer	0.094	0.144	CbGbCtD
Azathioprine—HPRT1—Nucleotide Metabolism—NME2—ovarian cancer	0.0115	0.265	CbGpPWpGaD
Azathioprine—GSTA1—embryo—ovarian cancer	0.00449	0.0432	CbGeAlD
Azathioprine—HPRT1—Nucleotide metabolism—NME2—ovarian cancer	0.0037	0.0855	CbGpPWpGaD
Azathioprine—GSTA1—epithelium—ovarian cancer	0.00367	0.0352	CbGeAlD
Azathioprine—HPRT1—myometrium—ovarian cancer	0.00354	0.034	CbGeAlD
Azathioprine—HPRT1—embryo—ovarian cancer	0.00341	0.0327	CbGeAlD
Azathioprine—GSTA2—embryo—ovarian cancer	0.00324	0.0312	CbGeAlD
Azathioprine—GSTA1—gonad—ovarian cancer	0.00305	0.0293	CbGeAlD
Azathioprine—GSTA1—uterus—ovarian cancer	0.00303	0.0291	CbGeAlD
Azathioprine—TPMT—myometrium—ovarian cancer	0.00299	0.0287	CbGeAlD
Azathioprine—GSTA1—Estrogen metabolism—CYP1B1—ovarian cancer	0.00293	0.0678	CbGpPWpGaD
Azathioprine—HPRT1—uterine cervix—ovarian cancer	0.00276	0.0265	CbGeAlD
Azathioprine—GSTA1—female reproductive system—ovarian cancer	0.00272	0.0262	CbGeAlD
Azathioprine—XDH—uterine cervix—ovarian cancer	0.00272	0.0261	CbGeAlD
Azathioprine—GSTA2—epithelium—ovarian cancer	0.00265	0.0254	CbGeAlD
Azathioprine—HPRT1—decidua—ovarian cancer	0.00263	0.0252	CbGeAlD
Azathioprine—HPRT1—endometrium—ovarian cancer	0.00249	0.0239	CbGeAlD
Azathioprine—GSTA1—female gonad—ovarian cancer	0.00248	0.0238	CbGeAlD
Azathioprine—XDH—endometrium—ovarian cancer	0.00246	0.0236	CbGeAlD
Azathioprine—TPMT—uterine cervix—ovarian cancer	0.00232	0.0223	CbGeAlD
Azathioprine—HPRT1—gonad—ovarian cancer	0.00231	0.0222	CbGeAlD
Azathioprine—HPRT1—uterus—ovarian cancer	0.0023	0.0221	CbGeAlD
Azathioprine—GSTM1—gonad—ovarian cancer	0.00226	0.0217	CbGeAlD
Azathioprine—TPMT—decidua—ovarian cancer	0.00221	0.0213	CbGeAlD
Azathioprine—GSTA2—gonad—ovarian cancer	0.0022	0.0211	CbGeAlD
Azathioprine—GSTA1—testis—ovarian cancer	0.0022	0.0211	CbGeAlD
Azathioprine—GSTA2—uterus—ovarian cancer	0.00219	0.021	CbGeAlD
Azathioprine—TPMT—endometrium—ovarian cancer	0.0021	0.0202	CbGeAlD
Azathioprine—HPRT1—female reproductive system—ovarian cancer	0.00206	0.0198	CbGeAlD
Azathioprine—XDH—female reproductive system—ovarian cancer	0.00204	0.0196	CbGeAlD
Azathioprine—GSTM1—female reproductive system—ovarian cancer	0.00202	0.0194	CbGeAlD
Azathioprine—GSTA2—female reproductive system—ovarian cancer	0.00197	0.0189	CbGeAlD
Azathioprine—TPMT—gonad—ovarian cancer	0.00195	0.0187	CbGeAlD
Azathioprine—HPRT1—bone marrow—ovarian cancer	0.00195	0.0187	CbGeAlD
Azathioprine—GSTM1—Estrogen metabolism—CYP1B1—ovarian cancer	0.00193	0.0445	CbGpPWpGaD
Azathioprine—HPRT1—female gonad—ovarian cancer	0.00188	0.018	CbGeAlD
Azathioprine—HPRT1—vagina—ovarian cancer	0.00187	0.0179	CbGeAlD
Azathioprine—XDH—vagina—ovarian cancer	0.00184	0.0177	CbGeAlD
Azathioprine—GSTM1—female gonad—ovarian cancer	0.00183	0.0176	CbGeAlD
Azathioprine—GSTA2—female gonad—ovarian cancer	0.00179	0.0172	CbGeAlD
Azathioprine—HPRT1—testis—ovarian cancer	0.00167	0.016	CbGeAlD
Azathioprine—TPMT—bone marrow—ovarian cancer	0.00164	0.0158	CbGeAlD
Azathioprine—GSTM1—testis—ovarian cancer	0.00163	0.0156	CbGeAlD
Azathioprine—GSTA2—testis—ovarian cancer	0.00159	0.0152	CbGeAlD
Azathioprine—TPMT—female gonad—ovarian cancer	0.00158	0.0152	CbGeAlD
Azathioprine—XDH—Nucleotide metabolism—NME2—ovarian cancer	0.00158	0.0365	CbGpPWpGaD
Azathioprine—TPMT—vagina—ovarian cancer	0.00157	0.0151	CbGeAlD
Azathioprine—TPMT—testis—ovarian cancer	0.00141	0.0135	CbGeAlD
Azathioprine—HPRT1—lymph node—ovarian cancer	0.00121	0.0116	CbGeAlD
Azathioprine—GSTM1—lymph node—ovarian cancer	0.00118	0.0113	CbGeAlD
Azathioprine—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00103	0.0238	CbGpPWpGaD
Azathioprine—TPMT—lymph node—ovarian cancer	0.00102	0.00978	CbGeAlD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000936	0.0216	CbGpPWpGaD
Azathioprine—XDH—Oxidative Stress—SOD1—ovarian cancer	0.000849	0.0196	CbGpPWpGaD
Azathioprine—HPRT1—Nucleotide metabolism—TYMS—ovarian cancer	0.00084	0.0194	CbGpPWpGaD
Azathioprine—XDH—Oxidative Stress—SOD2—ovarian cancer	0.000764	0.0177	CbGpPWpGaD
Azathioprine—GSTA2—Transcriptional activation by NRF2—PIK3CA—ovarian cancer	0.000636	0.0147	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—SLC5A5—ovarian cancer	0.000594	0.0137	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—SLC2A1—ovarian cancer	0.000574	0.0132	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—CYP1B1—ovarian cancer	0.000482	0.0111	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—SLC5A5—ovarian cancer	0.000401	0.00927	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000399	0.00923	CbGpPWpGaD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000391	0.00903	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—SLC5A5—ovarian cancer	0.00039	0.00901	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—CYP1B1—ovarian cancer	0.000389	0.00898	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—SLC2A1—ovarian cancer	0.000387	0.00895	CbGpPWpGaD
Azathioprine—TPMT—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000383	0.00886	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—SLC2A1—ovarian cancer	0.000377	0.00871	CbGpPWpGaD
Azathioprine—Myalgia—Topotecan—ovarian cancer	0.000375	0.00188	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000372	0.00187	CcSEcCtD
Azathioprine—Discomfort—Topotecan—ovarian cancer	0.00037	0.00186	CcSEcCtD
Azathioprine—Myalgia—Melphalan—ovarian cancer	0.000367	0.00184	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000364	0.00183	CcSEcCtD
Azathioprine—Liver injury—Doxorubicin—ovarian cancer	0.000364	0.00183	CcSEcCtD
Azathioprine—Neoplasm malignant—Doxorubicin—ovarian cancer	0.000359	0.0018	CcSEcCtD
Azathioprine—XDH—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000359	0.00829	CbGpPWpGaD
Azathioprine—XDH—Nucleotide metabolism—TYMS—ovarian cancer	0.000359	0.00828	CbGpPWpGaD
Azathioprine—Infection—Topotecan—ovarian cancer	0.000357	0.00179	CcSEcCtD
Azathioprine—Pancreatitis—Paclitaxel—ovarian cancer	0.000356	0.00179	CcSEcCtD
Azathioprine—Thrombocytopenia—Topotecan—ovarian cancer	0.000352	0.00176	CcSEcCtD
Azathioprine—Infection—Melphalan—ovarian cancer	0.00035	0.00175	CcSEcCtD
Azathioprine—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000349	0.00175	CcSEcCtD
Azathioprine—Skin disorder—Topotecan—ovarian cancer	0.000349	0.00175	CcSEcCtD
Azathioprine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000349	0.00175	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000348	0.00175	CcSEcCtD
Azathioprine—Anaemia—Vinorelbine—ovarian cancer	0.000348	0.00175	CcSEcCtD
Azathioprine—Pancytopenia—Paclitaxel—ovarian cancer	0.000345	0.00173	CcSEcCtD
Azathioprine—Thrombocytopenia—Melphalan—ovarian cancer	0.000344	0.00173	CcSEcCtD
Azathioprine—Skin disorder—Melphalan—ovarian cancer	0.000342	0.00171	CcSEcCtD
Azathioprine—Malaise—Vinorelbine—ovarian cancer	0.00034	0.0017	CcSEcCtD
Azathioprine—Leukopenia—Vinorelbine—ovarian cancer	0.000337	0.00169	CcSEcCtD
Azathioprine—HPRT1—Metabolism—NME2—ovarian cancer	0.000336	0.00777	CbGpPWpGaD
Azathioprine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000333	0.00167	CcSEcCtD
Azathioprine—Hepatocellular injury—Epirubicin—ovarian cancer	0.000331	0.00166	CcSEcCtD
Azathioprine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00033	0.00166	CcSEcCtD
Azathioprine—Hypotension—Melphalan—ovarian cancer	0.000329	0.00165	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000327	0.00164	CcSEcCtD
Azathioprine—Pneumonia—Paclitaxel—ovarian cancer	0.000326	0.00164	CcSEcCtD
Azathioprine—GSTA2—Biological oxidations—CYP1B1—ovarian cancer	0.000326	0.00753	CbGpPWpGaD
Azathioprine—Infestation NOS—Paclitaxel—ovarian cancer	0.000324	0.00163	CcSEcCtD
Azathioprine—Infestation—Paclitaxel—ovarian cancer	0.000324	0.00163	CcSEcCtD
Azathioprine—XDH—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000323	0.00746	CbGpPWpGaD
Azathioprine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000321	0.00161	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000321	0.00161	CcSEcCtD
Azathioprine—Myalgia—Vinorelbine—ovarian cancer	0.000321	0.00161	CcSEcCtD
Azathioprine—Arthralgia—Vinorelbine—ovarian cancer	0.000321	0.00161	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000321	0.00161	CcSEcCtD
Azathioprine—Body temperature increased—Chlorambucil—ovarian cancer	0.000319	0.0016	CcSEcCtD
Azathioprine—Abdominal pain—Chlorambucil—ovarian cancer	0.000319	0.0016	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000318	0.0016	CcSEcCtD
Azathioprine—Colitis—Epirubicin—ovarian cancer	0.000318	0.0016	CcSEcCtD
Azathioprine—GSTM1—Biological oxidations—CYP1B1—ovarian cancer	0.000317	0.00732	CbGpPWpGaD
Azathioprine—Discomfort—Vinorelbine—ovarian cancer	0.000317	0.00159	CcSEcCtD
Azathioprine—GSTM1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000313	0.00722	CbGpPWpGaD
Azathioprine—Aplastic anaemia—Epirubicin—ovarian cancer	0.000311	0.00156	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00031	0.00156	CcSEcCtD
Azathioprine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000307	0.00154	CcSEcCtD
Azathioprine—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000307	0.00154	CcSEcCtD
Azathioprine—Infection—Vinorelbine—ovarian cancer	0.000305	0.00153	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000304	0.00152	CcSEcCtD
Azathioprine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000301	0.00151	CcSEcCtD
Azathioprine—Neoplasm—Epirubicin—ovarian cancer	0.0003	0.0015	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000299	0.00691	CbGpPWpGaD
Azathioprine—Skin disorder—Vinorelbine—ovarian cancer	0.000299	0.0015	CcSEcCtD
Azathioprine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000297	0.00149	CcSEcCtD
Azathioprine—Feeling abnormal—Topotecan—ovarian cancer	0.000296	0.00148	CcSEcCtD
Azathioprine—Colitis—Doxorubicin—ovarian cancer	0.000294	0.00148	CcSEcCtD
Azathioprine—GSTA1—Metabolism—NME2—ovarian cancer	0.000294	0.00679	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000294	0.00147	CcSEcCtD
Azathioprine—Pancytopenia—Docetaxel—ovarian cancer	0.000293	0.00147	CcSEcCtD
Azathioprine—Haemoglobin—Paclitaxel—ovarian cancer	0.000292	0.00147	CcSEcCtD
Azathioprine—Haemorrhage—Paclitaxel—ovarian cancer	0.000291	0.00146	CcSEcCtD
Azathioprine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000288	0.00144	CcSEcCtD
Azathioprine—Hypotension—Vinorelbine—ovarian cancer	0.000287	0.00144	CcSEcCtD
Azathioprine—Body temperature increased—Topotecan—ovarian cancer	0.000284	0.00142	CcSEcCtD
Azathioprine—Abdominal pain—Topotecan—ovarian cancer	0.000284	0.00142	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00028	0.0014	CcSEcCtD
Azathioprine—Neoplasm—Doxorubicin—ovarian cancer	0.000277	0.00139	CcSEcCtD
Azathioprine—Pneumonia—Docetaxel—ovarian cancer	0.000276	0.00139	CcSEcCtD
Azathioprine—Diarrhoea—Chlorambucil—ovarian cancer	0.000276	0.00138	CcSEcCtD
Azathioprine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000275	0.00138	CcSEcCtD
Azathioprine—Erythema multiforme—Paclitaxel—ovarian cancer	0.000275	0.00138	CcSEcCtD
Azathioprine—Infestation—Docetaxel—ovarian cancer	0.000275	0.00138	CcSEcCtD
Azathioprine—Infestation NOS—Docetaxel—ovarian cancer	0.000275	0.00138	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000272	0.00137	CcSEcCtD
Azathioprine—Hepatic failure—Epirubicin—ovarian cancer	0.000268	0.00134	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000265	0.00133	CcSEcCtD
Azathioprine—Hypersensitivity—Topotecan—ovarian cancer	0.000265	0.00133	CcSEcCtD
Azathioprine—Immune system disorder—Paclitaxel—ovarian cancer	0.000263	0.00132	CcSEcCtD
Azathioprine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000262	0.00132	CcSEcCtD
Azathioprine—Chills—Paclitaxel—ovarian cancer	0.000261	0.00131	CcSEcCtD
Azathioprine—Arrhythmia—Paclitaxel—ovarian cancer	0.00026	0.0013	CcSEcCtD
Azathioprine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00026	0.0013	CcSEcCtD
Azathioprine—Hypersensitivity—Melphalan—ovarian cancer	0.000259	0.0013	CcSEcCtD
Azathioprine—Alopecia—Paclitaxel—ovarian cancer	0.000257	0.00129	CcSEcCtD
Azathioprine—Vomiting—Chlorambucil—ovarian cancer	0.000257	0.00129	CcSEcCtD
Azathioprine—Agranulocytosis—Docetaxel—ovarian cancer	0.000256	0.00129	CcSEcCtD
Azathioprine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000255	0.00128	CcSEcCtD
Azathioprine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000253	0.00127	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000251	0.00126	CcSEcCtD
Azathioprine—Haemoglobin—Docetaxel—ovarian cancer	0.000248	0.00124	CcSEcCtD
Azathioprine—Hepatic failure—Doxorubicin—ovarian cancer	0.000248	0.00124	CcSEcCtD
Azathioprine—Haemorrhage—Docetaxel—ovarian cancer	0.000247	0.00124	CcSEcCtD
Azathioprine—Diarrhoea—Topotecan—ovarian cancer	0.000246	0.00123	CcSEcCtD
Azathioprine—Body temperature increased—Vinorelbine—ovarian cancer	0.000243	0.00122	CcSEcCtD
Azathioprine—Abdominal pain—Vinorelbine—ovarian cancer	0.000243	0.00122	CcSEcCtD
Azathioprine—Diarrhoea—Melphalan—ovarian cancer	0.000241	0.00121	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.00024	0.00554	CbGpPWpGaD
Azathioprine—Nausea—Chlorambucil—ovarian cancer	0.00024	0.0012	CcSEcCtD
Azathioprine—Dizziness—Topotecan—ovarian cancer	0.000238	0.00119	CcSEcCtD
Azathioprine—TPMT—Metabolism—NME2—ovarian cancer	0.000237	0.00548	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000235	0.00118	CcSEcCtD
Azathioprine—Anaemia—Paclitaxel—ovarian cancer	0.000234	0.00117	CcSEcCtD
Azathioprine—Erythema multiforme—Docetaxel—ovarian cancer	0.000233	0.00117	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CCND1—ovarian cancer	0.000229	0.00529	CbGpPWpGaD
Azathioprine—Vomiting—Topotecan—ovarian cancer	0.000228	0.00115	CcSEcCtD
Azathioprine—Malaise—Paclitaxel—ovarian cancer	0.000228	0.00115	CcSEcCtD
Azathioprine—Leukopenia—Paclitaxel—ovarian cancer	0.000227	0.00114	CcSEcCtD
Azathioprine—Rash—Topotecan—ovarian cancer	0.000227	0.00114	CcSEcCtD
Azathioprine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000226	0.00114	CcSEcCtD
Azathioprine—Dermatitis—Topotecan—ovarian cancer	0.000226	0.00114	CcSEcCtD
Azathioprine—Headache—Topotecan—ovarian cancer	0.000225	0.00113	CcSEcCtD
Azathioprine—Vomiting—Melphalan—ovarian cancer	0.000224	0.00112	CcSEcCtD
Azathioprine—Immune system disorder—Docetaxel—ovarian cancer	0.000223	0.00112	CcSEcCtD
Azathioprine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000222	0.00111	CcSEcCtD
Azathioprine—Rash—Melphalan—ovarian cancer	0.000222	0.00111	CcSEcCtD
Azathioprine—Dermatitis—Melphalan—ovarian cancer	0.000222	0.00111	CcSEcCtD
Azathioprine—Chills—Docetaxel—ovarian cancer	0.000221	0.00111	CcSEcCtD
Azathioprine—Arrhythmia—Docetaxel—ovarian cancer	0.00022	0.0011	CcSEcCtD
Azathioprine—Alopecia—Docetaxel—ovarian cancer	0.000218	0.00109	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CYTB—ovarian cancer	0.000217	0.00501	CbGpPWpGaD
Azathioprine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000217	0.00109	CcSEcCtD
Azathioprine—Myalgia—Paclitaxel—ovarian cancer	0.000216	0.00108	CcSEcCtD
Azathioprine—Arthralgia—Paclitaxel—ovarian cancer	0.000216	0.00108	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000214	0.00107	CcSEcCtD
Azathioprine—Nausea—Topotecan—ovarian cancer	0.000213	0.00107	CcSEcCtD
Azathioprine—Discomfort—Paclitaxel—ovarian cancer	0.000213	0.00107	CcSEcCtD
Azathioprine—Diarrhoea—Vinorelbine—ovarian cancer	0.00021	0.00105	CcSEcCtD
Azathioprine—Nausea—Melphalan—ovarian cancer	0.000209	0.00105	CcSEcCtD
Azathioprine—Infection—Paclitaxel—ovarian cancer	0.000205	0.00103	CcSEcCtD
Azathioprine—Pancreatitis—Epirubicin—ovarian cancer	0.000204	0.00102	CcSEcCtD
Azathioprine—Dizziness—Vinorelbine—ovarian cancer	0.000203	0.00102	CcSEcCtD
Azathioprine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000202	0.00102	CcSEcCtD
Azathioprine—Skin disorder—Paclitaxel—ovarian cancer	0.000201	0.00101	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.0002	0.001	CcSEcCtD
Azathioprine—GSTA2—Metabolism—NME2—ovarian cancer	0.000199	0.00459	CbGpPWpGaD
Azathioprine—Anaemia—Docetaxel—ovarian cancer	0.000198	0.000995	CcSEcCtD
Azathioprine—Pancytopenia—Epirubicin—ovarian cancer	0.000197	0.00099	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—NRAS—ovarian cancer	0.000197	0.00455	CbGpPWpGaD
Azathioprine—Vomiting—Vinorelbine—ovarian cancer	0.000195	0.00098	CcSEcCtD
Azathioprine—Rash—Vinorelbine—ovarian cancer	0.000194	0.000972	CcSEcCtD
Azathioprine—Dermatitis—Vinorelbine—ovarian cancer	0.000194	0.000971	CcSEcCtD
Azathioprine—GSTM1—Metabolism—NME2—ovarian cancer	0.000193	0.00446	CbGpPWpGaD
Azathioprine—Hypotension—Paclitaxel—ovarian cancer	0.000193	0.000969	CcSEcCtD
Azathioprine—Headache—Vinorelbine—ovarian cancer	0.000193	0.000966	CcSEcCtD
Azathioprine—Leukopenia—Docetaxel—ovarian cancer	0.000192	0.000964	CcSEcCtD
Azathioprine—HPRT1—Metabolism—PPP1CC—ovarian cancer	0.000189	0.00438	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—BRIP1—ovarian cancer	0.000189	0.00438	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CYTB—ovarian cancer	0.000189	0.00438	CbGpPWpGaD
Azathioprine—Pancreatitis—Doxorubicin—ovarian cancer	0.000189	0.000946	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000188	0.000945	CcSEcCtD
Azathioprine—Pneumonia—Epirubicin—ovarian cancer	0.000186	0.000935	CcSEcCtD
Azathioprine—Infestation NOS—Epirubicin—ovarian cancer	0.000185	0.000929	CcSEcCtD
Azathioprine—Infestation—Epirubicin—ovarian cancer	0.000185	0.000929	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000184	0.000921	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—MYC—ovarian cancer	0.000184	0.00424	CbGpPWpGaD
Azathioprine—Arthralgia—Docetaxel—ovarian cancer	0.000183	0.000917	CcSEcCtD
Azathioprine—Myalgia—Docetaxel—ovarian cancer	0.000183	0.000917	CcSEcCtD
Azathioprine—Pancytopenia—Doxorubicin—ovarian cancer	0.000183	0.000916	CcSEcCtD
Azathioprine—Nausea—Vinorelbine—ovarian cancer	0.000183	0.000916	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000182	0.00091	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000178	0.000895	CcSEcCtD
Azathioprine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000175	0.000879	CcSEcCtD
Azathioprine—Infection—Docetaxel—ovarian cancer	0.000174	0.000873	CcSEcCtD
Azathioprine—Agranulocytosis—Epirubicin—ovarian cancer	0.000173	0.000867	CcSEcCtD
Azathioprine—Pneumonia—Doxorubicin—ovarian cancer	0.000172	0.000865	CcSEcCtD
Azathioprine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000172	0.00086	CcSEcCtD
Azathioprine—Infestation NOS—Doxorubicin—ovarian cancer	0.000171	0.00086	CcSEcCtD
Azathioprine—Infestation—Doxorubicin—ovarian cancer	0.000171	0.00086	CcSEcCtD
Azathioprine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00017	0.000854	CcSEcCtD
Azathioprine—Skin disorder—Docetaxel—ovarian cancer	0.00017	0.000854	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00017	0.000853	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—KRAS—ovarian cancer	0.00017	0.00392	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000169	0.000848	CcSEcCtD
Azathioprine—Haemoglobin—Epirubicin—ovarian cancer	0.000167	0.000839	CcSEcCtD
Azathioprine—Haemorrhage—Epirubicin—ovarian cancer	0.000166	0.000834	CcSEcCtD
Azathioprine—GSTA1—Metabolism—BRIP1—ovarian cancer	0.000166	0.00383	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PPP1CC—ovarian cancer	0.000166	0.00383	CbGpPWpGaD
Azathioprine—Hypotension—Docetaxel—ovarian cancer	0.000164	0.000821	CcSEcCtD
Azathioprine—Body temperature increased—Paclitaxel—ovarian cancer	0.000163	0.00082	CcSEcCtD
Azathioprine—Abdominal pain—Paclitaxel—ovarian cancer	0.000163	0.00082	CcSEcCtD
Azathioprine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000162	0.000813	CcSEcCtD
Azathioprine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00016	0.000802	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00016	0.000801	CcSEcCtD
Azathioprine—Erythema multiforme—Epirubicin—ovarian cancer	0.000157	0.000789	CcSEcCtD
Azathioprine—Haemoglobin—Doxorubicin—ovarian cancer	0.000155	0.000776	CcSEcCtD
Azathioprine—Haemorrhage—Doxorubicin—ovarian cancer	0.000154	0.000772	CcSEcCtD
Azathioprine—TPMT—Metabolism—CYTB—ovarian cancer	0.000153	0.00353	CbGpPWpGaD
Azathioprine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000152	0.000764	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000151	0.000759	CcSEcCtD
Azathioprine—Immune system disorder—Epirubicin—ovarian cancer	0.00015	0.000754	CcSEcCtD
Azathioprine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00015	0.000752	CcSEcCtD
Azathioprine—Chills—Epirubicin—ovarian cancer	0.000149	0.000749	CcSEcCtD
Azathioprine—Arrhythmia—Epirubicin—ovarian cancer	0.000149	0.000745	CcSEcCtD
Azathioprine—Alopecia—Epirubicin—ovarian cancer	0.000147	0.000737	CcSEcCtD
Azathioprine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000146	0.00073	CcSEcCtD
Azathioprine—Feeling abnormal—Docetaxel—ovarian cancer	0.000144	0.000724	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—HRAS—ovarian cancer	0.000144	0.00333	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NME2—ovarian cancer	0.000144	0.00332	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000143	0.000719	CcSEcCtD
Azathioprine—Diarrhoea—Paclitaxel—ovarian cancer	0.000141	0.000709	CcSEcCtD
Azathioprine—Immune system disorder—Doxorubicin—ovarian cancer	0.000139	0.000697	CcSEcCtD
Azathioprine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000139	0.000696	CcSEcCtD
Azathioprine—Body temperature increased—Docetaxel—ovarian cancer	0.000139	0.000695	CcSEcCtD
Azathioprine—Abdominal pain—Docetaxel—ovarian cancer	0.000139	0.000695	CcSEcCtD
Azathioprine—Chills—Doxorubicin—ovarian cancer	0.000138	0.000693	CcSEcCtD
Azathioprine—Arrhythmia—Doxorubicin—ovarian cancer	0.000138	0.00069	CcSEcCtD
Azathioprine—Dizziness—Paclitaxel—ovarian cancer	0.000137	0.000686	CcSEcCtD
Azathioprine—Alopecia—Doxorubicin—ovarian cancer	0.000136	0.000682	CcSEcCtD
Azathioprine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000134	0.000674	CcSEcCtD
Azathioprine—Anaemia—Epirubicin—ovarian cancer	0.000134	0.000671	CcSEcCtD
Azathioprine—TPMT—Metabolism—PPP1CC—ovarian cancer	0.000134	0.00308	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—BRIP1—ovarian cancer	0.000134	0.00308	CbGpPWpGaD
Azathioprine—Vomiting—Paclitaxel—ovarian cancer	0.000131	0.000659	CcSEcCtD
Azathioprine—Malaise—Epirubicin—ovarian cancer	0.000131	0.000655	CcSEcCtD
Azathioprine—Rash—Paclitaxel—ovarian cancer	0.00013	0.000654	CcSEcCtD
Azathioprine—Dermatitis—Paclitaxel—ovarian cancer	0.00013	0.000653	CcSEcCtD
Azathioprine—Leukopenia—Epirubicin—ovarian cancer	0.00013	0.00065	CcSEcCtD
Azathioprine—Headache—Paclitaxel—ovarian cancer	0.00013	0.00065	CcSEcCtD
Azathioprine—Hypersensitivity—Docetaxel—ovarian cancer	0.000129	0.000647	CcSEcCtD
Azathioprine—GSTA2—Metabolism—CYTB—ovarian cancer	0.000128	0.00296	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—YAP1—ovarian cancer	0.000127	0.00294	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CYTB—ovarian cancer	0.000125	0.00288	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000124	0.000624	CcSEcCtD
Azathioprine—Anaemia—Doxorubicin—ovarian cancer	0.000124	0.000621	CcSEcCtD
Azathioprine—Myalgia—Epirubicin—ovarian cancer	0.000123	0.000618	CcSEcCtD
Azathioprine—Arthralgia—Epirubicin—ovarian cancer	0.000123	0.000618	CcSEcCtD
Azathioprine—Nausea—Paclitaxel—ovarian cancer	0.000123	0.000616	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000122	0.000614	CcSEcCtD
Azathioprine—Discomfort—Epirubicin—ovarian cancer	0.000122	0.000611	CcSEcCtD
Azathioprine—Malaise—Doxorubicin—ovarian cancer	0.000121	0.000606	CcSEcCtD
Azathioprine—Leukopenia—Doxorubicin—ovarian cancer	0.00012	0.000602	CcSEcCtD
Azathioprine—Diarrhoea—Docetaxel—ovarian cancer	0.00012	0.000601	CcSEcCtD
Azathioprine—Infection—Epirubicin—ovarian cancer	0.000117	0.000589	CcSEcCtD
Azathioprine—Dizziness—Docetaxel—ovarian cancer	0.000116	0.000581	CcSEcCtD
Azathioprine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000116	0.00058	CcSEcCtD
Azathioprine—Skin disorder—Epirubicin—ovarian cancer	0.000115	0.000576	CcSEcCtD
Azathioprine—Myalgia—Doxorubicin—ovarian cancer	0.000114	0.000572	CcSEcCtD
Azathioprine—Arthralgia—Doxorubicin—ovarian cancer	0.000114	0.000572	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000113	0.000568	CcSEcCtD
Azathioprine—Discomfort—Doxorubicin—ovarian cancer	0.000113	0.000565	CcSEcCtD
Azathioprine—GSTA2—Metabolism—BRIP1—ovarian cancer	0.000112	0.00258	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PPP1CC—ovarian cancer	0.000112	0.00258	CbGpPWpGaD
Azathioprine—Vomiting—Docetaxel—ovarian cancer	0.000111	0.000559	CcSEcCtD
Azathioprine—GSTA1—Metabolism—YAP1—ovarian cancer	0.000111	0.00257	CbGpPWpGaD
Azathioprine—Rash—Docetaxel—ovarian cancer	0.00011	0.000554	CcSEcCtD
Azathioprine—Hypotension—Epirubicin—ovarian cancer	0.00011	0.000554	CcSEcCtD
Azathioprine—Dermatitis—Docetaxel—ovarian cancer	0.00011	0.000554	CcSEcCtD
Azathioprine—Headache—Docetaxel—ovarian cancer	0.00011	0.000551	CcSEcCtD
Azathioprine—GSTM1—Metabolism—PPP1CC—ovarian cancer	0.000109	0.00251	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—BRIP1—ovarian cancer	0.000109	0.00251	CbGpPWpGaD
Azathioprine—Infection—Doxorubicin—ovarian cancer	0.000109	0.000545	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000108	0.00054	CcSEcCtD
Azathioprine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000107	0.000537	CcSEcCtD
Azathioprine—Skin disorder—Doxorubicin—ovarian cancer	0.000106	0.000533	CcSEcCtD
Azathioprine—Nausea—Docetaxel—ovarian cancer	0.000104	0.000522	CcSEcCtD
Azathioprine—HPRT1—Metabolism—FASN—ovarian cancer	0.000104	0.00239	CbGpPWpGaD
Azathioprine—Hypotension—Doxorubicin—ovarian cancer	0.000102	0.000512	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000102	0.000512	CcSEcCtD
Azathioprine—HPRT1—Metabolism—SLC5A5—ovarian cancer	0.000102	0.00235	CbGpPWpGaD
Azathioprine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.96e-05	0.0005	CcSEcCtD
Azathioprine—XDH—Selenium Micronutrient Network—IL6—ovarian cancer	9.89e-05	0.00228	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—SLC2A1—ovarian cancer	9.84e-05	0.00227	CbGpPWpGaD
Azathioprine—Feeling abnormal—Epirubicin—ovarian cancer	9.74e-05	0.000488	CcSEcCtD
Azathioprine—Gastrointestinal pain—Epirubicin—ovarian cancer	9.66e-05	0.000485	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	9.44e-05	0.000473	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CYP1B1—ovarian cancer	9.44e-05	0.00218	CbGpPWpGaD
Azathioprine—Abdominal pain—Epirubicin—ovarian cancer	9.34e-05	0.000469	CcSEcCtD
Azathioprine—Body temperature increased—Epirubicin—ovarian cancer	9.34e-05	0.000469	CcSEcCtD
Azathioprine—XDH—Metabolism—CYTB—ovarian cancer	9.25e-05	0.00214	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—FASN—ovarian cancer	9.06e-05	0.00209	CbGpPWpGaD
Azathioprine—Feeling abnormal—Doxorubicin—ovarian cancer	9.01e-05	0.000452	CcSEcCtD
Azathioprine—TPMT—Metabolism—YAP1—ovarian cancer	8.95e-05	0.00207	CbGpPWpGaD
Azathioprine—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.94e-05	0.000448	CcSEcCtD
Azathioprine—GSTA1—Metabolism—SLC5A5—ovarian cancer	8.91e-05	0.00206	CbGpPWpGaD
Azathioprine—Hypersensitivity—Epirubicin—ovarian cancer	8.71e-05	0.000437	CcSEcCtD
Azathioprine—Body temperature increased—Doxorubicin—ovarian cancer	8.64e-05	0.000434	CcSEcCtD
Azathioprine—Abdominal pain—Doxorubicin—ovarian cancer	8.64e-05	0.000434	CcSEcCtD
Azathioprine—GSTA1—Metabolism—SLC2A1—ovarian cancer	8.6e-05	0.00199	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PPP2R1A—ovarian cancer	8.37e-05	0.00193	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CYP1B1—ovarian cancer	8.25e-05	0.00191	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PPP1CC—ovarian cancer	8.09e-05	0.00187	CbGpPWpGaD
Azathioprine—XDH—Metabolism—BRIP1—ovarian cancer	8.09e-05	0.00187	CbGpPWpGaD
Azathioprine—Diarrhoea—Epirubicin—ovarian cancer	8.09e-05	0.000406	CcSEcCtD
Azathioprine—Hypersensitivity—Doxorubicin—ovarian cancer	8.06e-05	0.000404	CcSEcCtD
Azathioprine—Dizziness—Epirubicin—ovarian cancer	7.82e-05	0.000392	CcSEcCtD
Azathioprine—HPRT1—Metabolism—ABCB1—ovarian cancer	7.77e-05	0.0018	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—TYMS—ovarian cancer	7.63e-05	0.00176	CbGpPWpGaD
Azathioprine—Vomiting—Epirubicin—ovarian cancer	7.51e-05	0.000377	CcSEcCtD
Azathioprine—GSTA2—Metabolism—YAP1—ovarian cancer	7.5e-05	0.00173	CbGpPWpGaD
Azathioprine—Diarrhoea—Doxorubicin—ovarian cancer	7.48e-05	0.000375	CcSEcCtD
Azathioprine—Rash—Epirubicin—ovarian cancer	7.45e-05	0.000374	CcSEcCtD
Azathioprine—Dermatitis—Epirubicin—ovarian cancer	7.45e-05	0.000373	CcSEcCtD
Azathioprine—Headache—Epirubicin—ovarian cancer	7.4e-05	0.000371	CcSEcCtD
Azathioprine—GSTA1—Metabolism—PPP2R1A—ovarian cancer	7.32e-05	0.00169	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—FASN—ovarian cancer	7.3e-05	0.00169	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—YAP1—ovarian cancer	7.3e-05	0.00169	CbGpPWpGaD
Azathioprine—Dizziness—Doxorubicin—ovarian cancer	7.23e-05	0.000363	CcSEcCtD
Azathioprine—TPMT—Metabolism—SLC5A5—ovarian cancer	7.18e-05	0.00166	CbGpPWpGaD
Azathioprine—Nausea—Epirubicin—ovarian cancer	7.02e-05	0.000352	CcSEcCtD
Azathioprine—Vomiting—Doxorubicin—ovarian cancer	6.95e-05	0.000349	CcSEcCtD
Azathioprine—TPMT—Metabolism—SLC2A1—ovarian cancer	6.93e-05	0.0016	CbGpPWpGaD
Azathioprine—Rash—Doxorubicin—ovarian cancer	6.9e-05	0.000346	CcSEcCtD
Azathioprine—Dermatitis—Doxorubicin—ovarian cancer	6.89e-05	0.000345	CcSEcCtD
Azathioprine—Headache—Doxorubicin—ovarian cancer	6.85e-05	0.000344	CcSEcCtD
Azathioprine—GSTA1—Metabolism—ABCB1—ovarian cancer	6.79e-05	0.00157	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—TYMS—ovarian cancer	6.67e-05	0.00154	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—CYP1B1—ovarian cancer	6.65e-05	0.00154	CbGpPWpGaD
Azathioprine—Nausea—Doxorubicin—ovarian cancer	6.5e-05	0.000326	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CAV1—ovarian cancer	6.15e-05	0.00142	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—FASN—ovarian cancer	6.12e-05	0.00141	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—SLC5A5—ovarian cancer	6.02e-05	0.00139	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—FASN—ovarian cancer	5.95e-05	0.00137	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PPP2R1A—ovarian cancer	5.9e-05	0.00136	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—SLC5A5—ovarian cancer	5.85e-05	0.00135	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—SLC2A1—ovarian cancer	5.81e-05	0.00134	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—SLC2A1—ovarian cancer	5.65e-05	0.00131	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PIK3CG—ovarian cancer	5.6e-05	0.00129	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CYP1B1—ovarian cancer	5.57e-05	0.00129	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—ABCB1—ovarian cancer	5.47e-05	0.00126	CbGpPWpGaD
Azathioprine—XDH—Metabolism—YAP1—ovarian cancer	5.43e-05	0.00125	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CYP1B1—ovarian cancer	5.42e-05	0.00125	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—TYMS—ovarian cancer	5.38e-05	0.00124	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CAV1—ovarian cancer	5.38e-05	0.00124	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PPP2R1A—ovarian cancer	4.94e-05	0.00114	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PIK3CD—ovarian cancer	4.92e-05	0.00114	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PIK3CG—ovarian cancer	4.9e-05	0.00113	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PPP2R1A—ovarian cancer	4.81e-05	0.00111	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—ABCB1—ovarian cancer	4.59e-05	0.00106	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—TYMS—ovarian cancer	4.51e-05	0.00104	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—ABCB1—ovarian cancer	4.46e-05	0.00103	CbGpPWpGaD
Azathioprine—XDH—Metabolism—FASN—ovarian cancer	4.42e-05	0.00102	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—TYMS—ovarian cancer	4.38e-05	0.00101	CbGpPWpGaD
Azathioprine—XDH—Metabolism—SLC5A5—ovarian cancer	4.35e-05	0.001	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—CAV1—ovarian cancer	4.33e-05	0.001	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PIK3CD—ovarian cancer	4.3e-05	0.000994	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PIK3CB—ovarian cancer	4.29e-05	0.000991	CbGpPWpGaD
Azathioprine—XDH—Metabolism—SLC2A1—ovarian cancer	4.2e-05	0.000971	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CYP1B1—ovarian cancer	4.03e-05	0.00093	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PIK3CG—ovarian cancer	3.95e-05	0.000912	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PIK3CB—ovarian cancer	3.75e-05	0.000867	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTEN—ovarian cancer	3.71e-05	0.000857	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CAV1—ovarian cancer	3.63e-05	0.000839	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PPP2R1A—ovarian cancer	3.57e-05	0.000825	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CAV1—ovarian cancer	3.53e-05	0.000816	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PIK3CD—ovarian cancer	3.47e-05	0.000801	CbGpPWpGaD
Azathioprine—XDH—Metabolism—ABCB1—ovarian cancer	3.32e-05	0.000766	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PIK3CG—ovarian cancer	3.31e-05	0.000764	CbGpPWpGaD
Azathioprine—XDH—Metabolism—TYMS—ovarian cancer	3.26e-05	0.000753	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTEN—ovarian cancer	3.24e-05	0.000749	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PIK3CG—ovarian cancer	3.22e-05	0.000743	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PIK3CB—ovarian cancer	3.02e-05	0.000699	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PIK3CD—ovarian cancer	2.91e-05	0.000672	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PIK3CD—ovarian cancer	2.83e-05	0.000653	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CAV1—ovarian cancer	2.63e-05	0.000606	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PIK3CA—ovarian cancer	2.62e-05	0.000604	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTEN—ovarian cancer	2.61e-05	0.000604	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PIK3CB—ovarian cancer	2.53e-05	0.000585	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PIK3CB—ovarian cancer	2.47e-05	0.000569	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PIK3CG—ovarian cancer	2.39e-05	0.000552	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PIK3CA—ovarian cancer	2.29e-05	0.000528	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTEN—ovarian cancer	2.19e-05	0.000506	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—AKT1—ovarian cancer	2.14e-05	0.000494	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTEN—ovarian cancer	2.13e-05	0.000492	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PIK3CD—ovarian cancer	2.1e-05	0.000486	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—AKT1—ovarian cancer	1.87e-05	0.000432	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PIK3CA—ovarian cancer	1.84e-05	0.000426	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PIK3CB—ovarian cancer	1.83e-05	0.000423	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTEN—ovarian cancer	1.58e-05	0.000366	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PIK3CA—ovarian cancer	1.54e-05	0.000357	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—AKT1—ovarian cancer	1.51e-05	0.000348	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PIK3CA—ovarian cancer	1.5e-05	0.000347	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—AKT1—ovarian cancer	1.26e-05	0.000292	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—AKT1—ovarian cancer	1.23e-05	0.000284	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PIK3CA—ovarian cancer	1.12e-05	0.000258	CbGpPWpGaD
Azathioprine—XDH—Metabolism—AKT1—ovarian cancer	9.12e-06	0.000211	CbGpPWpGaD
